Software & Developer Tools
Arbor Biotechnologies
United Statesarbor.bio
Arbor Biotechnologies is a series c plus startup. 2 investors tracked.
Activeseries-c-plus
series-c-plus
Stage
2018
Founded
2
Investors
About Arbor Biotechnologies
Arbor Biotechnologies is a startup founded in 2018 based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Software & Developer Tools. Brouky records 2 investors associated with the company.
Arbor Biotechnologies is a clinical-stage biotechnology company focused on discovering and developing next-generation gene editing therapeutics for genetic diseases affecting the liver and central nervous system.
Explore Arbor Biotechnologies's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.